Gulfstream Park in Hallandale, Beach, Fla., has not set a timetable for possible future contact with Florida racing regulators on chairman Frank Stronach’s goal of phasing out use of legal race-day medications such as the anti-bleeding drug Salix.

In a July 13 letter to Milton Champion, director of the Florida Division of Pari-Mutuel Wagering (DPMW), Stronach asked if that state agency would "help me implement a program that will phase out all race-day medication, including (Salix)." One horsemen’s representative called the proposal a "terrible mistake."

The Florida DPMW is reviewing the letter, agency spokeswoman Beth Frady said July 20. "We are waiting for a response from the state," Tim Ritvo, Gulfstream’s vice president for racing, said July 20 when asked if Gulfstream Park planned to send the Florida DPMW a more detailed request for changes in state medication rules.

According to the Florida DPMW, it is possible to change state rules for Thoroughbred tracks through a regulatory process. Or, Gulfstream or another track could set medication rules that would apply only to that track.

Any state rule changes would require a process of at least several months. That essentially rules out the possibility of any changes for Gulfstream’s next meet, from Dec. 3, 2011, to April 8, 2012.

In the state process, the DPMW from its own findings or recommendations from others would need to determine if there are reasons to consider any rules changes. It would then schedule one or more public workshops, and use any testimony in a process for preparing proposed rules.

In his July 13 le